Gemifloxacin

DB01155

small molecule approved investigational

Deskripsi

Gemifloxacin is a quinolone antibacterial agent with a broad-spectrum activity that is used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia. It is available in oral formulations. Gemifloxacin acts by inhibiting DNA synthesis through the inhibition of both DNA gyrase and topoisomerase IV, which are essential for bacterial growth.

Struktur Molekul 2D

Berat 389.3809
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 7 (± 2) hours
Volume Distribusi * 1.66 to 12.12 L/kg
Klirens (Clearance) * renal cl=11.6+/- 3.9 L/hr [Healthy subjects receiving repeat doses of 320 mg orally]

Absorpsi

Rapidly absorbed from the gastrointestinal tract. The absolute bioavailability averages approximately 71%.

Metabolisme

Gemifloxacin is metabolized to a limited extent by the liver. All metabolites formed are minor (<10% of the administered oral dose); the principal ones are N-acetyl gemifloxacin, the E-isomer of gemifloxacin and the carbamyl glucuronide of gemifloxacin.

Rute Eliminasi

Gemifloxacin and its metabolites are excreted via dual routes of excretion.Following oral administration of gemifloxacin to healthy subjects, a mean (± SD) of 61 ± 9.5% of the dose was excreted in the feces and 36 ± 9.3% in the urine as unchanged drug and metabolites. The mean (± SD) renal clearance following repeat doses of 320 mg was approximately 11.6 ± 3.9 L/hr (range 4.6-6 L/hr), which indicates active secretion is involved in the renal excretion of gemifloxacin.

Interaksi Makanan

1 Data
  • 1. Take with or without food. The absorption is unaffected by food.

Interaksi Obat

935 Data
Ivabradine Ivabradine may increase the QTc-prolonging activities of Gemifloxacin.
Didanosine Didanosine can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quinapril Quinapril can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium acetate Calcium acetate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sevelamer Sevelamer can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Dextran Iron Dextran can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium Calcium can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium carbonate Calcium carbonate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Lanthanum carbonate Lanthanum carbonate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric carboxymaltose Ferric carboxymaltose can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron sucrose Iron sucrose can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric pyrophosphate Ferric pyrophosphate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium citrate Calcium citrate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium gluconate Calcium gluconate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric sulfate Ferric sulfate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric cation Ferric cation can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tetraferric tricitrate decahydrate Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Lanthanum III cation Lanthanum III cation can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium polycarbophil Calcium polycarbophil can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric oxyhydroxide Ferric oxyhydroxide can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sucralfate Sucralfate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Gemifloxacin.
Nitrofurantoin The therapeutic efficacy of Gemifloxacin can be decreased when used in combination with Nitrofurantoin.
Probenecid Probenecid may decrease the excretion rate of Gemifloxacin which could result in a higher serum level.
Mycophenolate mofetil The serum concentration of Mycophenolate mofetil can be decreased when it is combined with Gemifloxacin.
Mycophenolic acid The serum concentration of Mycophenolic acid can be decreased when it is combined with Gemifloxacin.
Picosulfuric acid The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Gemifloxacin.
Insulin human The therapeutic efficacy of Insulin human can be increased when used in combination with Gemifloxacin.
Insulin lispro The therapeutic efficacy of Insulin lispro can be increased when used in combination with Gemifloxacin.
Insulin pork The therapeutic efficacy of Insulin pork can be increased when used in combination with Gemifloxacin.
Troglitazone The therapeutic efficacy of Troglitazone can be increased when used in combination with Gemifloxacin.
Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Gemifloxacin.
Sulfisoxazole The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Gemifloxacin.
Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Gemifloxacin.
Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Gemifloxacin.
Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Gemifloxacin.
Rosiglitazone The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Gemifloxacin.
Acetohexamide The therapeutic efficacy of Acetohexamide can be increased when used in combination with Gemifloxacin.
Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Gemifloxacin.
Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Gemifloxacin.
Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Gemifloxacin.
Pentamidine The therapeutic efficacy of Pentamidine can be increased when used in combination with Gemifloxacin.
Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Gemifloxacin.
Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Gemifloxacin.
Phenformin The therapeutic efficacy of Phenformin can be increased when used in combination with Gemifloxacin.
Sulfamethoxazole The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Gemifloxacin.
Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Gemifloxacin.
Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Gemifloxacin.
Gliclazide The therapeutic efficacy of Gliclazide can be increased when used in combination with Gemifloxacin.
Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Gemifloxacin.
Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Gemifloxacin.
Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Gemifloxacin.
Gliquidone The therapeutic efficacy of Gliquidone can be increased when used in combination with Gemifloxacin.
Mitiglinide The therapeutic efficacy of Mitiglinide can be increased when used in combination with Gemifloxacin.
Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Gemifloxacin.
Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Gemifloxacin.
Exenatide The therapeutic efficacy of Exenatide can be increased when used in combination with Gemifloxacin.
Mecasermin The therapeutic efficacy of Mecasermin can be increased when used in combination with Gemifloxacin.
Pramlintide The therapeutic efficacy of Pramlintide can be increased when used in combination with Gemifloxacin.
Glisoxepide The therapeutic efficacy of Glisoxepide can be increased when used in combination with Gemifloxacin.
Insulin aspart The therapeutic efficacy of Insulin aspart can be increased when used in combination with Gemifloxacin.
Insulin glulisine The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Gemifloxacin.
Glymidine The therapeutic efficacy of Glymidine can be increased when used in combination with Gemifloxacin.
AICA ribonucleotide The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Gemifloxacin.
Buformin The therapeutic efficacy of Buformin can be increased when used in combination with Gemifloxacin.
Vildagliptin The therapeutic efficacy of Vildagliptin can be increased when used in combination with Gemifloxacin.
Voglibose The therapeutic efficacy of Voglibose can be increased when used in combination with Gemifloxacin.
NN344 The therapeutic efficacy of NN344 can be increased when used in combination with Gemifloxacin.
AMG-222 The therapeutic efficacy of AMG-222 can be increased when used in combination with Gemifloxacin.
Bisegliptin The therapeutic efficacy of Bisegliptin can be increased when used in combination with Gemifloxacin.
Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Gemifloxacin.
Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Gemifloxacin.
Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Gemifloxacin.
Liraglutide The therapeutic efficacy of Liraglutide can be increased when used in combination with Gemifloxacin.
Gosogliptin The therapeutic efficacy of Gosogliptin can be increased when used in combination with Gemifloxacin.
Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Gemifloxacin.
Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Gemifloxacin.
Glibornuride The therapeutic efficacy of Glibornuride can be increased when used in combination with Gemifloxacin.
Benfluorex The therapeutic efficacy of Benfluorex can be increased when used in combination with Gemifloxacin.
Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Gemifloxacin.
Albiglutide The therapeutic efficacy of Albiglutide can be increased when used in combination with Gemifloxacin.
Dulaglutide The therapeutic efficacy of Dulaglutide can be increased when used in combination with Gemifloxacin.
Lobeglitazone The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Gemifloxacin.
Netoglitazone The therapeutic efficacy of Netoglitazone can be increased when used in combination with Gemifloxacin.
Rivoglitazone The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Gemifloxacin.
Ciglitazone The therapeutic efficacy of Ciglitazone can be increased when used in combination with Gemifloxacin.
Lixisenatide The therapeutic efficacy of Lixisenatide can be increased when used in combination with Gemifloxacin.
Insulin beef The therapeutic efficacy of Insulin beef can be increased when used in combination with Gemifloxacin.
Insulin degludec The therapeutic efficacy of Insulin degludec can be increased when used in combination with Gemifloxacin.
Insulin peglispro The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Gemifloxacin.
Insulin tregopil The therapeutic efficacy of Insulin tregopil can be increased when used in combination with Gemifloxacin.
Ipragliflozin The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Gemifloxacin.
Dutogliptin The therapeutic efficacy of Dutogliptin can be increased when used in combination with Gemifloxacin.
Allicin The therapeutic efficacy of Allicin can be increased when used in combination with Gemifloxacin.
Tofogliflozin The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Gemifloxacin.
Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Gemifloxacin.
2,4-thiazolidinedione The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Gemifloxacin.
Teneligliptin The therapeutic efficacy of Teneligliptin can be increased when used in combination with Gemifloxacin.
Omarigliptin The therapeutic efficacy of Omarigliptin can be increased when used in combination with Gemifloxacin.
Carmegliptin The therapeutic efficacy of Carmegliptin can be increased when used in combination with Gemifloxacin.

Target Protein

DNA gyrase subunit A gyrA
DNA gyrase subunit B gyrB
DNA gyrase subunit A gyrA
DNA topoisomerase 4 subunit A parC

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 5 • International brands: 1
Produk
  • Factive
    Tablet, film coated • 320 mg/1 • Oral • US • Approved
  • Factive
    Tablet • 320 mg/1 • Oral • US • Approved
  • Factive
    Tablet • 320 mg/1 • Oral • US • Approved
  • Factive
    Tablet • 320 mg/1 • Oral • US • Approved
  • Factive
    Tablet • 320 mg • Oral • Canada • Approved
International Brands
  • Factiv

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul